KDIGO provided recommendations on SGLT2 inhibitors and nonsteroidal MRAs in patients with diabetes and CKD

Authors: Matthew van Norman, Donald A. Molony

Published: 2023-05-01

DOI: 10.7326/j23-0023

Source: Full article

Abstract

No abstract found.